Vancouver, Canada

Tong He

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Canexia Health Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tong He. Retrieved from https://idiyas.com/inventor/tong-he-0tzu0y3p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tong He

Introduction

Tong He is an accomplished inventor based in Vancouver, Canada. He has made significant contributions to the field of molecular quality assurance, particularly in the context of sequencing technologies. His work is pivotal in enhancing the reliability and accuracy of genetic analysis.

Latest Patents

Tong He holds a patent for "Molecular quality assurance methods for use in sequencing." This invention relates to quality assurance methods utilized in amplification techniques, such as Next Generation Sequencing (NGS). His innovative approach aims to improve the quality and reliability of sequencing results.

Career Highlights

Tong He is currently associated with Canexia Health Inc., a company that focuses on advancing genomic testing and precision medicine. His role at Canexia Health allows him to apply his expertise in molecular quality assurance to real-world applications, contributing to the advancement of healthcare technologies.

Collaborations

Tong He has collaborated with notable professionals in his field, including Samuel Aparicio and Sohrab Shah. These collaborations have further enriched his research and development efforts, leading to impactful innovations in molecular quality assurance.

Conclusion

Tong He's contributions to the field of molecular quality assurance and his innovative patent demonstrate his commitment to advancing genetic sequencing technologies. His work continues to influence the landscape of precision medicine and genomic testing.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…